ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

Mesenchymal Stem Cells: A New Approach for Treating Bronchopulmonary Dysplasia | Biomedgrid

Journal: American Journal of Biomedical Science & Research (Vol.5, No. 5)

Publication Date:

Authors : ;

Page : 377-381

Keywords : Prematurity; Bronchopulmonary dysplasia; Mesenchymal stem/stromal cells; Lung disease; AJBSR;

Source : Downloadexternal Find it from : Google Scholarexternal

Abstract

In spite of improved clinical management premature babies are highly susceptible to several neonatal related-morbidities, namely respiratory, neurological, and gastrointestinal. Bronchopulmonary dysplasia (BPD) is the most common lung disorder in premature babies. Present therapeutic options are mainly supportive and do not completely cure BPD, mainly because of its multifactorial pathogenesis. Mesenchymal stem/stromal cells (MSCs) have materialized as a highly promising therapeutic option for alleviating BPD. The many facets of this novel therapy are discussed in this review

Last modified: 2019-11-15 14:57:35